J. Mintzer
Impact in
- Neurology top 5%
- Neurological Disorders and Treatments
- Neurological Disease Mechanisms and Treatments
- Cerebrovascular and genetic disorders
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Schizophrenia research and treatment
Papers in
-
- Neuroscience and Neuropharmacology Research 2
- Neuropeptides and Animal Physiology 2
-
- Receptor Mechanisms and Signaling 2
- Co-authors
- Robert D. Helme (1 shared paper)Raymond Pratt (1 shared paper)David Wilkinson (1 shared paper)Rachelle S. Doody (1 shared paper)Andrew Kertesz (1 shared paper)Kevin Taubman (1 shared paper)Kate Zhong (1 shared paper)Nancy Devine (1 shared paper)
- Journals
- European Neuropsychopharmacology (2 papers)American Journal of Psychiatry (2 papers)Cellular and Molecular Life Sciences (2 papers)Expert Opinion on Pharmacotherapy (1 paper)Current Alzheimer Research (1 paper)
- Partner nations
- United StatesIsraelAustralia
In The Last Decade
J. Mintzer
13 papers receiving 494 citations
Peers
Comparison fields: 5 of 75
- Neurology 146
- Psychiatry and Mental health 216
- Geriatrics and Gerontology 20
- Biological Psychiatry 13
- Pharmacology 80
Countries citing papers authored by J. Mintzer
This map shows the geographic impact of J. Mintzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mintzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mintzer more than expected).
Fields of papers citing papers by J. Mintzer
This network shows the impact of papers produced by J. Mintzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mintzer. The network helps show where J. Mintzer may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Mintzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 290 | |
| 2 | 2007 | 104 | |
| 3 | 2016 | 54 | |
| 4 | 1995 | 35 | |
| 5 | 1984 | 17 | |
| 6 | 1985 | 11 | |
| 7 | 2008 | 7 | |
| 8 | 1986 | 5 | |
| 9 | Heritability of forskolin and hormone-stimulated adenylate cyclase activity in human lymphocytes. | 1985 | 5 |
| 10 | Notably higher rates of vascular risk factors and dementia among African Americans in South Carolina: opportunities for public health intervention. | 2008 | 3 |
| 11 | 2003 | 3 | |
| 12 | 1986 | 2 | |
| 13 | 2002 | 2 |
About J. Mintzer
J. Mintzer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Clinical Psychology, Biological Psychiatry and Behavioral Neuroscience, having authored 13 papers that have together received 538 indexed citations. Recurring topics across this work include Healthcare Decision-Making and Restraints (2 papers), Adenosine and Purinergic Signaling (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Tryptophan and brain disorders (2 papers), Receptor Mechanisms and Signaling (2 papers), Neuropeptides and Animal Physiology (2 papers), Stress Responses and Cortisol (2 papers) and Genetic Syndromes and Imprinting (1 paper). The work is most often cited by research in Neurology (146 citations), Psychiatry and Mental health (216 citations), Geriatrics and Gerontology (20 citations), Biological Psychiatry (13 citations) and Pharmacology (80 citations). J. Mintzer has collaborated with scholars based in United States, Israel and Australia. Frequent co-authors include Robert D. Helme, Raymond Pratt, David Wilkinson, Rachelle S. Doody, Andrew Kertesz, Kevin Taubman, Kate Zhong, Nancy Devine, Pierre N. Tariot and Margaret Minkwitz. Their work appears in journals such as European Neuropsychopharmacology, American Journal of Psychiatry, Cellular and Molecular Life Sciences, Expert Opinion on Pharmacotherapy and Current Alzheimer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.